Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2 (March 2014) (SHC 9138) | FÖD Volksgesundheit

25/04/2014

ionizing radiations domain

Advies 9138 - 223RACL2
Niederländisch
hgr_9138_advies_223racl2.pdf PDF document - 440.47 KB
Avis 9138 - Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2
Französisch
css_9138_avis_223racl2.pdf PDF document - 410.98 KB
Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2 (March 2014) (SHC 9138)
Englisch
Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2 (March 2014) (SHC 9138).pdf PDF document - 407.53 KB